The week in health tech, explained in plain English.Get the free newsletter →
October 24, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Health IT

Oracle Health Bets on AI EHR for Double-Digit Growth

Oracle is staking the future of its health business on artificial intelligence. The company said it expects Oracle Health to reach double-digit revenue growth in fiscal 2027, driven by a new AI-powered overhaul of the Cerner electronic health record it acquired in 2022, according to Becker's Hospital Review.

The projection landed alongside strong corporate results. Oracle reported record fourth-quarter and full-year fiscal 2026 numbers, with total revenue reaching $67.4 billion, up 17% year over year. The health unit has lagged the broader business since the Cerner deal, making the redesigned, AI-native EHR central to Oracle's pitch that it can modernize clinical software and win back hospital customers.

For health systems, the move signals intensifying competition with Epic, the market leader, as both vendors race to embed generative AI into documentation, ordering, and clinical workflows. The practical question for buyers is whether Oracle's rebuilt platform can deliver on usability and reliability, areas where Cerner has historically trailed, before the fiscal 2027 growth targets come due.

More in Health IT

Health IT

Epic Opens Its Platform Wider to AI and Outside Developers

Epic used its Open@Epic developer conference to open its platform wider to outside AI and apps while reminding developers that the resulting traffic runs on hospitals' infrastructure.

Why it matters: As the dominant EHR vendor, Epic's decision to open its platform shapes how and where clinical AI gets deployed across most U.S. hospitals.

Health IT

After AI Go-Live, Who Owns Monitoring? Often No One

Health systems scrutinize AI before go-live, but post-deployment monitoring responsibilities often remain undefined, leaving no clear owner when models drift.

Why it matters: Unmonitored AI models can quietly degrade in clinical settings, putting patient safety at risk when no one is accountable for watching performance after launch.